Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Terminated 3Recruiting 3Active not recruiting 3Completed 2

Sponsor Class

NIH 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Glioblastoma 13Prostatic Neoplasms 11Breast Neoplasms 10Lung Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Neoplasm Metastasis 7Squamous Cell Carcinoma of Head and Neck 6Sarcoma 5Oropharyngeal Neoplasms 5Neoplasms 4Histiocytoma, Malignant Fibrous 4Head and Neck Neoplasms 4Brain Neoplasms 4Astrocytoma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma, Synovial 3Rhabdomyosarcoma 3Melanoma 3Liposarcoma 3Leiomyosarcoma 3Hodgkin Disease 3Glioma 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Hepatocellular 3Burkitt Lymphoma 3Adenocarcinoma Of Esophagus 3Stomach Neoplasms 2Sarcoma, Ewing 2

Interventions

Gemcitabine 19pembrolizumab 17Cisplatin 17Nivolumab 15atezolizumab 12Magnetic Resonance Spectroscopy 10durvalumab 9Specimen Handling 9Cystectomy 9Carboplatin 7Ipilimumab 6Fluorouracil 6avelumab 5Surgical Procedures, Operative 5Mitomycin 5sacituzumab govitecan 4erdafitinib 4enfortumab vedotin 4Immunoglobulin G 4Disulfides 4Biopsy 4tremelimumab 3cabozantinib 3Transurethral Resection of Bladder 3Surveys and Questionnaires 3Radiation 3Platinum 3Paclitaxel 3Leucovorin 3Docetaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Urinary Bladder Neoplasms × Radiation × Clear all
NCT04216290 2026-05-22

A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

National Cancer Institute (NCI)

Phase 2 Active not recruiting
11 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT03132922 2026-05-07

MAGE-A4ᶜ¹º³²T for Multi-Tumor

USWM, LLC (dba US WorldMeds)

Phase 1 Active not recruiting
71 enrolled 20 charts
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Sarcoma, Synovial, Liposarcoma, Myxoid

NCT03775265 2026-05-04

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
475 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡